Literature DB >> 27903732

Parkin Deficiency Reduces Hippocampal Glutamatergic Neurotransmission by Impairing AMPA Receptor Endocytosis.

Giuseppe P Cortese1, Mei Zhu1, Damian Williams2, Sarah Heath3, Clarissa L Waites4.   

Abstract

Mutations in the gene encoding Parkin, an E3 ubiquitin ligase, lead to juvenile-onset Parkinson's disease by inducing the selective death of midbrain dopaminergic neurons. Accumulating evidence indicates that Parkin also has an important role in excitatory glutamatergic neurotransmission, although its precise mechanism of action remains unclear. Here, we investigate Parkin's role at glutamatergic synapses of rat hippocampal neurons. We find that Parkin-deficient neurons exhibit significantly reduced AMPA receptor (AMPAR)-mediated currents and cell-surface expression, and that these phenotypes result from decreased postsynaptic expression of the adaptor protein Homer1, which is necessary for coupling AMPAR endocytic zones with the postsynaptic density. Accordingly, Parkin loss of function leads to the reduced density of postsynaptic endocytic zones and to impaired AMPAR internalization. These findings demonstrate a novel and essential role for Parkin in glutamatergic neurotransmission, as a stabilizer of postsynaptic Homer1 and the Homer1-linked endocytic machinery necessary for maintaining normal cell-surface AMPAR levels. SIGNIFICANCE STATEMENT: Mutations in Parkin, a ubiquitinating enzyme, lead to the selective loss of midbrain dopaminergic neurons and juvenile-onset Parkinson's disease (PD). Parkin loss of function has also been shown to alter hippocampal glutamatergic neurotransmission, providing a potential explanation for PD-associated cognitive impairment. However, very little is known about Parkin's specific sites or mechanisms of action at glutamatergic synapses. Here, we show that Parkin deficiency leads to decreased AMPA receptor-mediated activity due to disruption of the postsynaptic endocytic zones required for maintaining proper cell-surface AMPA receptor levels. These findings demonstrate a novel role for Parkin in synaptic AMPA receptor internalization and suggest a Parkin-dependent mechanism for hippocampal dysfunction that may explain cognitive deficits associated with some forms of PD.
Copyright © 2016 the authors 0270-6474/16/3612243-16$15.00/0.

Entities:  

Keywords:  AMPA receptor; Homer; Parkin; endocytic zone; synapse

Mesh:

Substances:

Year:  2016        PMID: 27903732      PMCID: PMC5148221          DOI: 10.1523/JNEUROSCI.1473-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  58 in total

1.  Parkin: a multipurpose neuroprotective agent?

Authors:  Mel B Feany; Leo J Pallanck
Journal:  Neuron       Date:  2003-04-10       Impact factor: 17.173

2.  Molecular mechanisms for regulation of AMPAR trafficking by PICK1.

Authors:  J G Hanley
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

3.  hCASK and hDlg associate in epithelia, and their src homology 3 and guanylate kinase domains participate in both intramolecular and intermolecular interactions.

Authors:  S L Nix; A H Chishti; J M Anderson; Z Walther
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

Review 4.  Cognitive impairment in Parkinson's disease.

Authors:  Jeremy Cosgrove; Jane Elizabeth Alty; Stuart Jamieson
Journal:  Postgrad Med J       Date:  2015-03-26       Impact factor: 2.401

Review 5.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

Authors:  Per Svenningsson; Eric Westman; Clive Ballard; Dag Aarsland
Journal:  Lancet Neurol       Date:  2012-08       Impact factor: 44.182

6.  LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis.

Authors:  Samer Matta; Kristof Van Kolen; Raquel da Cunha; Geert van den Bogaart; Wim Mandemakers; Katarzyna Miskiewicz; Pieter-Jan De Bock; Vanessa A Morais; Sven Vilain; Dominik Haddad; Lore Delbroek; Jef Swerts; Lucía Chávez-Gutiérrez; Giovanni Esposito; Guy Daneels; Eric Karran; Matthew Holt; Kris Gevaert; Diederik W Moechars; Bart De Strooper; Patrik Verstreken
Journal:  Neuron       Date:  2012-09-20       Impact factor: 17.173

7.  LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism.

Authors:  Amaia M Arranz; Lore Delbroek; Kristof Van Kolen; Marco R Guimarães; Wim Mandemakers; Guy Daneels; Samer Matta; Sara Calafate; Hamdy Shaban; Pieter Baatsen; Pieter-Jan De Bock; Kris Gevaert; Pieter Vanden Berghe; Patrik Verstreken; Bart De Strooper; Diederik Moechars
Journal:  J Cell Sci       Date:  2015-02-01       Impact factor: 5.285

8.  Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission.

Authors:  Emiliano M Rial Verde; Jane Lee-Osbourne; Paul F Worley; Roberto Malinow; Hollis T Cline
Journal:  Neuron       Date:  2006-11-09       Impact factor: 17.173

9.  Alternative splicing generates different parkin protein isoforms: evidences in human, rat, and mouse brain.

Authors:  Soraya Scuderi; Valentina La Cognata; Filippo Drago; Sebastiano Cavallaro; Velia D'Agata
Journal:  Biomed Res Int       Date:  2014-07-16       Impact factor: 3.411

Review 10.  Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions.

Authors:  Joel Raskin; Jeffrey Cummings; John Hardy; Kory Schuh; Robert A Dean
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

View more
  12 in total

Review 1.  The Role of AMPARs Composition and Trafficking in Synaptic Plasticity and Diseases.

Authors:  Qing-Lin Wu; Yan Gao; Jun-Tong Li; Wen-Yu Ma; Nai-Hong Chen
Journal:  Cell Mol Neurobiol       Date:  2021-08-26       Impact factor: 4.231

2.  Prkn knockout mice show autistic-like behaviors and aberrant synapse formation.

Authors:  Yuda Huo; Wen Lu; Yuan Tian; Qingming Hou; Heng-Ye Man
Journal:  iScience       Date:  2022-06-10

Review 3.  Are we listening to everything the PARK genes are telling us?

Authors:  Deanna L Benson; George W Huntley
Journal:  J Comp Neurol       Date:  2019-02-08       Impact factor: 3.215

4.  Non-Motor Symptoms of Parkinson's Disease: The Neurobiology of Early Psychiatric and Cognitive Dysfunction.

Authors:  Ayan Hussein; Christopher A Guevara; Pamela Del Valle; Swati Gupta; Deanna L Benson; George W Huntley
Journal:  Neuroscientist       Date:  2021-05-08       Impact factor: 7.235

Review 5.  Synapses in neurodegenerative diseases.

Authors:  Jae Ryul Bae; Sung Hyun Kim
Journal:  BMB Rep       Date:  2017-05       Impact factor: 4.778

6.  Presynaptic Dysfunction by Familial Factors in Parkinson Disease.

Authors:  Wongyoung Lee; Soulmee Koh; Soondo Hwang; Sung Hyun Kim
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

Review 7.  Mechanisms of AMPA Receptor Endosomal Sorting.

Authors:  Gabrielle T Parkinson; Jonathan G Hanley
Journal:  Front Mol Neurosci       Date:  2018-12-05       Impact factor: 5.639

8.  Parkin contributes to synaptic vesicle autophagy in Bassoon-deficient mice.

Authors:  Sheila Hoffmann-Conaway; Marisa M Brockmann; Katharina Schneider; Anil Annamneedi; Kazi Atikur Rahman; Christine Bruns; Kathrin Textoris-Taube; Thorsten Trimbuch; Karl-Heinz Smalla; Christian Rosenmund; Eckart D Gundelfinger; Craig Curtis Garner; Carolina Montenegro-Venegas
Journal:  Elife       Date:  2020-05-04       Impact factor: 8.140

9.  Secreted Amyloid Precursor Protein-Alpha Enhances LTP Through the Synthesis and Trafficking of Ca2+-Permeable AMPA Receptors.

Authors:  Rhys W Livingstone; Megan K Elder; Anurag Singh; Courteney M Westlake; Warren P Tate; Wickliffe C Abraham; Joanna M Williams
Journal:  Front Mol Neurosci       Date:  2021-04-01       Impact factor: 5.639

10.  Parkinson's disease-linked Parkin mutations impair glutamatergic signaling in hippocampal neurons.

Authors:  Mei Zhu; Giuseppe P Cortese; Clarissa L Waites
Journal:  BMC Biol       Date:  2018-09-10       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.